Influences of neurotransmission-related genetic polymorphisms on depression, anxiety and stress

Authors

  • Wan Lei Thien Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Sabah, Malaysia
  • Chrystalle Bih Yuan Tan School of Psychology and Vision Sciences, University of Leicester, Leicester, United Kingdom
  • Kai Ling Chin Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Sabah, Malaysia

DOI:

https://doi.org/10.31117/neuroscirn.v6i2.215

Keywords:

Mental health, Brain-derived neurotrophic factor, Serotonin receptor, Monoamine oxidase, Catechol-O-methyltransferase

Abstract

Over 10% of the world population suffer from mental disorders. In particular, depression causes about 800,000 suicide cases annually, while anxiety is the most common mental disorder. Stresses from work, life, and health have been identified as the common triggers for the two mental disorders. Eventhough mental disorders are treatable and validated tools are available to diagnose, many individuals are left untreated due to different factors, such as a lack of trained personnel and stigma. Neuroscience research indicates that mental disorders could be hereditary, where genes involved in determining behavioural variants. Disturbance in brain communication, resulting from abnormalities in neurogenesis, neurotransmission, and enzymatic degradation, have led to negative emotional states. This mini-review will highlight some important genes in the neurotransmitter systems and explore the relationship between gene polymorphisms and emotional states (i.e., depression, anxiety, and stress). The genes that will be discussed in this mini-review include brain-derived neurotrophic factor (BDNF) which is involved in neuron development, serotonin-transporter-linked polymorphic region (5-HTTLPR) and 5-hydroxytryptamine receptor 1A (5-HT1A) which are involved in serotonin neurotransmitter action potential propagation, and monoamine oxidase A (MAOA) and catechol-O-methyltransferase (COMT), which are involved in neurotransmitter catabolism.

References

Åberg, E., Fandiño-Losada, A., Sjöholm, L. K., Forsell, Y., & Lavebratt, C. (2011). The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study. Journal of Affective Disorders, 129(1–3), 158–166. https://doi.org/10.1016/j.jad.2010.08.009

Aldoghachi, A. F., Tor, Y. S., Redzun, S. Z., Lokman, K. a. B., Razaq, N. a. A., Shahbudin, A. S. M., Badamasi, I. M., Cheah, P. S., Stanslas, J., Veerakumarasivam, A., Rosli, R., Ibrahim, N., Lye, M. S., & Ling, K. H. (2019). Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients. PLoS ONE, 14(1), e0211241. https://doi.org/10.1371/journal.pone.0211241

Al-Hatamleh, M. a. I., Hussin, T. a. B. S. R., Taib, W. R. W., & Ismail, I. (2019). The Brain-Derived Neurotrophic Factor (BDNF) gene Val66Met (rs6265) polymorphism and stress among preclinical medical students in Malaysia. Journal of Taibah University Medical Sciences, 14(5), 431–438. https://doi.org/10.1016/j.jtumed.2019.09.003

American Psychological Association. (2020). Stress in America 2020: A national mental health crisis. https://www.apa.org/news/press/releases/stress/2020/report-october

Amireault, P., Sibon, D., & Côté, F. (2013). Life without Peripheral Serotonin: Insights from Tryptophan Hydroxylase 1 Knockout Mice Reveal the Existence of Paracrine/Autocrine Serotonergic Networks. ACS Chemical Neuroscience, 4(1), 64–71. https://doi.org/10.1021/cn300154j

Armbruster, D., Mueller, A., Strobel, A., Lesch, K., Brocke, B., & Kirschbaum, C. (2012). Children under stress – COMT genotype and stressful life events predict cortisol increase in an acute social stress paradigm. The International Journal of Neuropsychopharmacology, 15(09), 1229–1239. https://doi.org/10.1017/s1461145711001763

Bækken, P. M., Skorpen, F., Stordal, E., Zwart, J., & Hagen, K. (2008). Depression and anxiety in relation to catechol-O-methyltransferase Val158Met genotype in the general population: The Nord-Trøndelag Health Study (HUNT). BMC Psychiatry, 8(1), 48. https://doi.org/10.1186/1471-244x-8-48

Batterham, P. J., Calear, A. L., Sunderland, M., Carragher, N., & Brewer, J. L. (2016). Online screening and feedback to increase help-seeking for mental health problems: population-based randomised controlled trial. British Journal of Psychiatry Open, 2(1), 67–73. https://doi.org/10.1192/bjpo.bp.115.001552

Blier, P. U., Piñeyro, G., Mansari, M. E., Bergeron, R., & De Montigny, C. (1998). Role of Somatodendritic 5-HT Autoreceptors in Modulating 5-HT Neurotransmissiona. Annals of the New York Academy of Sciences, 861(1 ADVANCES IN S), 204–216. https://doi.org/10.1111/j.1749-6632.1998.tb10192.x

Broerman, R. L. (2017). Diathesis-Stress Model. Springer eBooks, 1–3. https://doi.org/10.1007/978-3-319-28099-8_891-1

Brummett, B. H., Krystal, A. D., Siegler, I. C., Kuhn, C. M., Surwit, R. S., Züchner, S., Ashley-Koch, A. E., Barefoot, J. C., & Williams, R. B. (2007). Associations of a Regulatory Polymorphism of Monoamine Oxidase-A Gene Promoter (MAOA-uVNTR) With Symptoms of Depression and Sleep Quality. Psychosomatic Medicine, 69(5), 396–401. https://doi.org/10.1097/psy.0b013e31806d040b

Caire, M. J., Reddy, V. & Varacallo, M. (2023, March 27). Physiology, Synapse. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK526047/

Cerasa, A., Quattrone, A., Piras, F., Mangone, G., Magariello, A., Fagioli, S., Girardi, P., Muglia, M., Caltagirone, C., & Spalletta, G. (2013). 5-HTTLPR, anxiety and gender interaction moderates right amygdala volume in healthy subjects. Social Cognitive and Affective Neuroscience, 9(10), 1537–1545. https://doi.org/10.1093/scan/nst144

Chaieb, L., Antal, A., Ambrus, G. G., & Paulus, W. (2014). Brain-derived neurotrophic factor: its impact upon neuroplasticity and neuroplasticity inducing transcranial brain stimulation protocols. Neurogenetics, 15(1), 1–11. https://doi.org/10.1007/s10048-014-0393-1

Chu, L., Sun, X., Jia, X., Li, D., Gao, P., Zhang, Y., & Li, J. (2022). The Relationship Among BDNF Val66Met Polymorphism, Plasma BDNF Level, and Trait Anxiety in Chinese Patients With Panic Disorder. Frontiers in Psychiatry, 13, 932235. https://doi.org/10.3389/fpsyt.2022.932235

Coleman, J. A., Green, E. M., & Gouaux, E. (2016). X-ray structures and mechanism of the human serotonin transporter. Nature, 532(7599), 334–339. https://doi.org/10.1038/nature17629

Crum, A. J., Akinola, M., Turnwald, B. P., Kaptchuk, T. J., & Hall, K. T. (2018). Catechol-O-Methyltransferase moderates effect of stress mindset on affect and cognition. PLoS ONE, 13(4), e0195883. https://doi.org/10.1371/journal.pone.0195883

Dattani, S., Ritchie, H., & Roser, M. (2021). Mental Health. Our World in data. https://ourworldindata.org/mental-health

Donaldson, Z. R., Francois, B. G. L., Santos, T. C., Almli, L. M., Boldrini, M., Champagne, F. A., Arango, V., Mann, J. J., Stockmeier, C. A., Galfalvy, H., Albert, P. R., Ressler, K. J., & Hen, R. (2016). The functional serotonin 1a receptor promoter polymorphism, rs6295, is associated with psychiatric illness and differences in transcription. Translational Psychiatry, 6(3), e746. https://doi.org/10.1038/tp.2015.226

Duman, R. S., & Monteggia, L. M. (2006). A Neurotrophic Model for Stress-Related Mood Disorders. Biological Psychiatry, 59(12), 1116–1127. https://doi.org/10.1016/j.biopsych.2006.02.013

Dunn, E. C., Brown, R. E., Dai, Y. G., Rosand, J., Nugent, N. R., Amstadter, A. B., & Smoller, J. W. (2015). Genetic Determinants of Depression. Harvard Review of Psychiatry, 23(1), 1–18. https://doi.org/10.1097/hrp.0000000000000054

Fox, N. A., Zeytinoglu, S., Valadez, E. A., Buzzell, G. A., Morales, S., & Henderson, H. A. (2022). Annual Research Review: Developmental pathways linking early behavioral inhibition to later anxiety. Journal of Child Psychology and Psychiatry, 64(4), 537–561. https://doi.org/10.1111/jcpp.13702

Gnegy, M. E. (2012). Catecholamines. Basic Neurochemistry (Eighth Edition), Academic Press. pp. 283–299. https://doi.org/10.1016/b978-0-12-374947-5.00014-6

Gottschalk, M. B., & Domschke, K. (2017). Genetics of generalized anxiety disorder and related traits. Dialogues in Clinical Neuroscience, 19(2), 159–168. https://doi.org/10.31887/dcns.2017.19.2/kdomschke

Guo, W., Zhang, Z. P., Mu, J., Liu, D., Zhao, L., Yao, Z., & Song, J. J. (2016). Relationship between 5-HTTLPR polymorphism and post-stroke depression. Genetics and Molecular Research, 15(1), gmr.15017460. https://doi.org/10.4238/gmr.15017460

Haavik, J., Blau, N., & Thöny, B. (2008). Mutations in human monoamine-related neurotransmitter pathway genes. Human Mutation, 29(7), 891–902. https://doi.org/10.1002/humu.20700

Hamon, M., & Blier, P. (2013). Monoamine neurocircuitry in depression and strategies for new treatments. Progress in Neuro-psychopharmacology & Biological Psychiatry, 45, 54–63. https://doi.org/10.1016/j.pnpbp.2013.04.009

Juhasz, G., Gonda, X., Hullám, G., Eszlari, N., Kovacs, D., Lazary, J., Pap, D., Petschner, P., Elliott, R., Deakin, J. F. W., Anderson, I., Antal, P., Lesch, K., & Bagdy, G. (2015). Variability in the Effect of 5-HTTLPR on Depression in a Large European Population: The Role of Age, Symptom Profile, Type and Intensity of Life Stressors. PLoS ONE, 10(3), e0116316. https://doi.org/10.1371/journal.pone.0116316

Kerschensteiner, M., Gallmeier, E., Behrens, L., Leal, V. V., Misgeld, T., Klinkert, W. E., Kolbeck, R., Hoppe, E., Oropeza-Wekerle, R. L., Bartke, I., Stadelmann, C., Lassmann, H., Wekerle, H., & Hohlfeld, R. (1999). Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. The Journal of Experimental Medicine, 189(5), 865–870. https://doi.org/10.1084/jem.189.5.865

Khan S, Khan R. A. (2017). Chronic Stress Leads to Anxiety and Depression. Ann Psychiatry Ment Health 5(1): 1091

Kobayashi, K., & Nagatsu, T. (2012). Tyrosine Hydroxylase. Primer on the Autonomic Nervous System (Third Edition), Academic Press. (pp. 45–47). https://doi.org/10.1016/b978-0-12-386525-0.00007-x

Lesch, K., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B., Petri, S., Benjamin, J., Müller, C., Hamer, D. H., & Murphy, D. L. (1996). Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region. Science, 274(5292), 1527–1531. https://doi.org/10.1126/science.274.5292.1527

Liu, Y., & Lu, Z. (2013). The Relationship Between MAOA Gene Polymorphism and Test Anxiety. Twin Research and Human Genetics, 16(6), 1103–1106. https://doi.org/10.1017/thg.2013.71

Lohoff, F. W. (2010). Overview of the Genetics of Major Depressive Disorder. Current Psychiatry Reports, 12(6), 539–546. https://doi.org/10.1007/s11920-010-0150-6

Mamounas, L. A., Blue, M. E., Siuciak, J. A., & Altar, C. A. (1995). Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. The Journal of Neuroscience, 15(12), 7929–7939. https://doi.org/10.1523/jneurosci.15-12-07929.1995

Marwaha, S., Palmer, E., Suppes, T., Cons, E., Young, A. H., & Upthegrove, R. (2022). Novel and emerging treatments for major depression. The Lancet, 401(10371), 141–153. https://doi.org/10.1016/s0140-6736(22)02080-3

Mcleod, S. (2023). What is the Stress Response. Simply Psychology. https://www.simplypsychology.org/stress-biology.html

Mekli, K., Payton, A., Miyajima, F., Platt, H., Thomas, E., Downey, D., Lloyd-Williams, K., Chase, D., Toth, Z., Elliott, R., Ollier, W. E. R., Anderson, I., Deakin, J. F. W., Bagdy, G., & Juhasz, G. (2011). The HTR1A and HTR1B receptor genes influence stress-related information processing. European Neuropsychopharmacology, 21(1), 129–139. https://doi.org/10.1016/j.euroneuro.2010.06.013

Melas, P. A., Wei, Y. B., Wong, C. C. Y., Sjöholm, L. K., Åberg, E., Mill, J., Schalling, M., Forsell, Y., & Lavebratt, C. (2013). Genetic and epigenetic associations of MAOA and NR3C1 with depression and childhood adversities. The International Journal of Neuropsychopharmacology, 16(7), 1513–1528. https://doi.org/10.1017/s1461145713000102

Ming, Q., Zhang, Y., Yi, J., Wang, X., Zhu, X., & Yao, S. (2015). Serotonin transporter gene polymorphism (5-HTTLPR) L allele interacts with stress to increase anxiety symptoms in Chinese adolescents: a multiwave longitudinal study. BMC Psychiatry, 15(1), 248. https://doi.org/10.1186/s12888-015-0639-y

Molendijk, M. L., Bus, B. A., Spinhoven, P., Penninx, B. W., Kenis, G., Prickaerts, J., Voshaar, R. C. O., & Elzinga, B. M. (2010). Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment. Molecular Psychiatry, 16(11), 1088–1095. https://doi.org/10.1038/mp.2010.98

Moreira, F. P., Fabião, J. D., Bittencourt, G., Wiener, C. D., Jansen, K., Oses, J. P., De Avila Quevedo, L., De Mattos Souza, L. D., Crispim, D., Portela, L. O. C., Pinheiro, R. T., Lara, D. R., Kaster, M. P., Da Silva, R. H. A., & Ghisleni, G. (2015). The Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder. Psychiatric Genetics, 25(5), 201–207. https://doi.org/10.1097/ypg.0000000000000097

Moret, C., & Briley, M. (2011). The importance of norepinephrine in depression. Neuropsychiatric Disease and Treatment, 7(Supplement 1), 9–13. https://doi.org/10.2147/ndt.s19619

Murakami, F., Shimomura, T., Kotani, K., Ikawa, S., Nanba, E., & Adachi, K. (1999). Anxiety traits associated with a polymorphism in the serotonin transporter gene regulatory region in the Japanese. Journal of Human Genetics, 44(1), 15–17. https://doi.org/10.1007/s100380050098

Oral, E. A., Canpolat, S., Yildirim, S., Gulec, M., Aliyev, E., & Aydin, N. (2012). Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Research Bulletin, 88(5), 454–459. https://doi.org/10.1016/j.brainresbull.2012.03.005

Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016). Major depressive disorder. Nature Reviews Disease Primers, 2(1), 16065. https://doi.org/10.1038/nrdp.2016.65

Panesar, K., & Guzman, F. (2013). The 5-HT1A Receptor in Psychopharmacology. The Psychopharmacology Institute. https://psychopharmacologyinstitute.com/publication/5-ht1a-receptors-in-psychopharmacology-2123

Pate, A. N., Reed, B. N., Cain, J., & Schlesselman, L. S. (2023). Improving and Expanding Research on Burnout and Stress in the Academy. The American Journal of Pharmaceutical Education, 87(1), ajpe8907. https://doi.org/10.5688/ajpe8907

Peel, A. J., Oginni, O., Assary, E., Krebs, G., Lockhart, C., McGregor, T., Palaiologou, E., Ronald, A., Danese, A., & Eley, T. C. (2022). A multivariate genetic analysis of anxiety sensitivity, environmental sensitivity and reported life events in adolescents. Journal of Child Psychology and Psychiatry, 64(2), 289–298. https://doi.org/10.1111/jcpp.13725

Petito, A., Altamura, M., Iuso, S., Padalino, F. A., Sessa, F., D’Andrea, G., Margaglione, M., & Bellomo, A. (2016). The Relationship between Personality Traits, the 5HTT Polymorphisms, and the Occurrence of Anxiety and Depressive Symptoms in Elite Athletes. PLoS ONE, 11(6), e0156601. https://doi.org/10.1371/journal.pone.0156601

Plieger, T., Melchers, M., Felten, A., Lieser, T., Meermann, R., & Reuter, M. (2019). Moderator Effects of Life Stress on the Association between MAOA-uVNTR, Depression, and Burnout. Neuropsychobiology, 78(2), 86–94. https://doi.org/10.1159/000499085

Potter, G. G., Taylor, W., McQuoid, D. R., Steffens, D. C., Welsh-Bohmer, K. A., & Krishnan, K. R. R. (2009). The COMT Val158Met polymorphism and cognition in depressed and nondepressed older adults. International Journal of Geriatric Psychiatry, 24(10), 1127–1133. https://doi.org/10.1002/gps.2235

Sarter, M., Bruno, J. F., & Parikh, V. (2006). Abnormal Neurotransmitter Release Underlying Behavioral and Cognitive Disorders: Toward Concepts of Dynamic and Function-Specific Dysregulation. Neuropsychopharmacology, 32(7), 1452–1461. https://doi.org/10.1038/sj.npp.1301285

Savitz, J., Lucki, I., & Drevets, W. C. (2009). 5-HT1A receptor function in major depressive disorder. Progress in Neurobiology, 88(1), 17–31. https://doi.org/10.1016/j.pneurobio.2009.01.009

Siuciak, J. A., Lewis, D. R., Wiegand, S. J., & Lindsay, R. M. (1997). Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF). Pharmacology, Biochemistry and Behavior, 56(1), 131–137. https://doi.org/10.1016/s0091-3057(96)00169-4

Smoller, J. W. (2016). The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders. Neuropsychopharmacology, 41(1), 297–319. https://doi.org/10.1038/npp.2015.266

Stein, M. B., Fallin, M. D., Schork, N. J., & Gelernter, J. (2005). COMT Polymorphisms and Anxiety-Related Personality Traits. Neuropsychopharmacology, 30(11), 2092–2102. https://doi.org/10.1038/sj.npp.1300787

Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000). Genetic Epidemiology of Major Depression: Review and Meta-Analysis. American Journal of Psychiatry, 157(10), 1552–1562. https://doi.org/10.1176/appi.ajp.157.10.1552

Tadić, A., Müller, M. M., Rujescu, D., Kohnen, R., Stassen, H. H., Dahmen, N., & Szegedi, A. (2007). TheMAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. American Journal of Medical Genetics - Neuropsychiatric Genetics, 144B(3), 325–331. https://doi.org/10.1002/ajmg.b.30462

Tadić, A., Rujescu, D., Szegedi, A., Giegling, I., Singer, P., Möller, H., & Dahmen, N. (2002). Association of aMAOAgene variant with generalized anxiety disorder, but not with panic disorder or major depression. American Journal of Medical Genetics - Neuropsychiatric Genetics, 117B(1), 1–6. https://doi.org/10.1002/ajmg.b.10013

Villafuerte, S., Vallabhaneni, K., Śliwerska, E., Baune, B. T., Young, E. A., & Burmeister, M. (2009). SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. Psychiatric Genetics, 19(6), 281–291. https://doi.org/10.1097/ypg.0b013e32832a506e

Weinshilboum, R. M., & Axelrod, J. (1971). Serum Dopamine-Beta-Hydroxylase Activity. Circulation Research, 28(3), 307–315. https://doi.org/10.1161/01.res.28.3.307

World Health Organization. (2017). Depression and other common mental disorders: global health estimates. https://apps.who.int/iris/handle/10665/254610

World Health Organization. (2022). Mental health. https://www.who.int/news-room/fact-sheets/detail/mental-health-strengthening-our-response

World Health Organization. (2023). Depressive disorder (depression). https://www.who.int/news-room/fact-sheets/detail/depression

Yang, Y., Zhao, M., Zhang, Y., Shen, X., & Yuan, Y. (2016). Correlation of 5-HTT, BDNF and NPSR1 gene polymorphisms with anxiety and depression in asthmatic patients. International Journal of Molecular Medicine, 38(1), 65–74. https://doi.org/10.3892/ijmm.2016.2581

Yim, H. W., Lee, S. H., Lee, H. Y., Potenza, M. N., Kwon, J. H., Koo, H. S., Kweon, Y., Bhang, S. Y., & Choi, J. (2018). Discordance between self-report and clinical diagnosis of Internet gaming disorder in adolescents. Scientific Reports, 8(1), 10084. https://doi.org/10.1038/s41598-018-28478-8

Youssef, M. K., Underwood, M. A., Huang, Y., Hsiung, S., Liu, Y., Simpson, N. R., Bakalian, M. J., Rosoklija, G., Dwork, A. J., Arango, V., & Mann, J. J. (2018). Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide. The International Journal of Neuropsychopharmacology, 21(6), 528–538. https://doi.org/10.1093/ijnp/pyy008

Zhong, F., Liu, L., Wei, J., Hu, Z., Li, L., Wang, S., Xu, J., Zhou, X., Li, C., Yang, Z., & Dai, R. (2019). Brain-Derived Neurotrophic Factor Precursor in the Hippocampus Regulates Both Depressive and Anxiety-Like Behaviors in Rats. Frontiers in Psychiatry, 9, 776. https://doi.org/10.3389/fpsyt.2018.00776

Downloads

Published

2023-06-25

How to Cite

Thien, W. L., Tan, C. B. Y. and Chin, K. L. (2023) “Influences of neurotransmission-related genetic polymorphisms on depression, anxiety and stress”, Neuroscience Research Notes, 6(2), pp. 215.1–215.11. doi: 10.31117/neuroscirn.v6i2.215.